Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV
Awarded
The competition has ended and a winner has been selected.
- Qualification deadline
- May 27,Expired
- Award
- Price only
Brief
O Instituto Português de Oncologia do Porto Francisco Gentil, EPE, celebrou um contrato com a GlaxoSmithkline - Produtos Farmacêuticos, Lda. para o fornecimento de Dostarlimab 50 mg/ml solução injetável em frascos de 10 ml IV, com um valor final de 100 €. O critério de adjudicação foi o preço global proposto.
Farmasøytisk engroshandel
Result
- GLAXO SMITHKLINE- PROD.FARMAC., LDAWinner
- 1Number of bids
- €100Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Preço global proposto
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Instituto Português de Oncologia do Porto Francisco Gentil, EPE
From the notice
Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV
Contact
compras@ipoporto.min-saude.pt- Result · PrequalificationType
- 33600000Main codePharmaceutical products